nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—CYP1B1—melanoma	0.26	0.777	CbGaD
Tamoxifen—ABCB1—melanoma	0.0745	0.223	CbGaD
Tamoxifen—ABCG2—Vemurafenib—melanoma	0.0532	0.13	CbGbCtD
Tamoxifen—CYP1B1—Docetaxel—melanoma	0.0384	0.0938	CbGbCtD
Tamoxifen—CYP1A1—Dacarbazine—melanoma	0.0377	0.0919	CbGbCtD
Tamoxifen—ABCG2—Dactinomycin—melanoma	0.0354	0.0863	CbGbCtD
Tamoxifen—CYP2E1—Dacarbazine—melanoma	0.0291	0.071	CbGbCtD
Tamoxifen—CYP1A2—Carmustine—melanoma	0.0278	0.0678	CbGbCtD
Tamoxifen—CYP1A2—Vemurafenib—melanoma	0.0219	0.0536	CbGbCtD
Tamoxifen—CYP3A4—Temozolomide—melanoma	0.021	0.0512	CbGbCtD
Tamoxifen—ABCC2—Docetaxel—melanoma	0.0202	0.0493	CbGbCtD
Tamoxifen—ABCG2—Docetaxel—melanoma	0.0183	0.0446	CbGbCtD
Tamoxifen—CYP2D6—Vemurafenib—melanoma	0.0181	0.0441	CbGbCtD
Tamoxifen—CYP1A2—Dacarbazine—melanoma	0.0168	0.0411	CbGbCtD
Tamoxifen—CYP3A7—Docetaxel—melanoma	0.0135	0.0329	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.0135	0.0329	CbGbCtD
Tamoxifen—ABCB1—Dactinomycin—melanoma	0.0128	0.0311	CbGbCtD
Tamoxifen—CYP3A4—Vemurafenib—melanoma	0.0115	0.0281	CbGbCtD
Tamoxifen—CYP3A5—Docetaxel—melanoma	0.0101	0.0247	CbGbCtD
Tamoxifen—ABCB1—Docetaxel—melanoma	0.00658	0.0161	CbGbCtD
Tamoxifen—CYP3A4—Docetaxel—melanoma	0.00395	0.00963	CbGbCtD
Tamoxifen—DHCR7—hair follicle—melanoma	0.00174	0.0707	CbGeAlD
Tamoxifen—SULT1A1—neck—melanoma	0.00164	0.0667	CbGeAlD
Tamoxifen—EBPL—head—melanoma	0.000871	0.0355	CbGeAlD
Tamoxifen—DHCR7—retina—melanoma	0.000859	0.035	CbGeAlD
Tamoxifen—CES1—neck—melanoma	0.000795	0.0324	CbGeAlD
Tamoxifen—CYP1B1—hair follicle—melanoma	0.000756	0.0308	CbGeAlD
Tamoxifen—DHCR7—skin of body—melanoma	0.000754	0.0307	CbGeAlD
Tamoxifen—FMO3—eye—melanoma	0.000749	0.0305	CbGeAlD
Tamoxifen—CYP1A1—skin epidermis—melanoma	0.000749	0.0305	CbGeAlD
Tamoxifen—SULT1A1—head—melanoma	0.000692	0.0282	CbGeAlD
Tamoxifen—ESR2—neck—melanoma	0.000689	0.028	CbGeAlD
Tamoxifen—FMO1—mammalian vulva—melanoma	0.000688	0.028	CbGeAlD
Tamoxifen—DHCR7—mammalian vulva—melanoma	0.000688	0.028	CbGeAlD
Tamoxifen—ESRRA—mammalian vulva—melanoma	0.000677	0.0276	CbGeAlD
Tamoxifen—ESR1—blood vessel—melanoma	0.000659	0.0268	CbGeAlD
Tamoxifen—EBPL—lymph node—melanoma	0.00061	0.0248	CbGeAlD
Tamoxifen—FMO3—mammalian vulva—melanoma	0.000595	0.0242	CbGeAlD
Tamoxifen—DHCR7—head—melanoma	0.000492	0.02	CbGeAlD
Tamoxifen—FMO1—head—melanoma	0.000492	0.02	CbGeAlD
Tamoxifen—SULT1A1—lymph node—melanoma	0.000484	0.0197	CbGeAlD
Tamoxifen—ESRRA—head—melanoma	0.000484	0.0197	CbGeAlD
Tamoxifen—ESR1—neck—melanoma	0.000472	0.0192	CbGeAlD
Tamoxifen—FMO3—head—melanoma	0.000425	0.0173	CbGeAlD
Tamoxifen—SIGMAR1—eye—melanoma	0.000397	0.0162	CbGeAlD
Tamoxifen—CYP1B1—eye—melanoma	0.000377	0.0154	CbGeAlD
Tamoxifen—DHCR7—lymph node—melanoma	0.000345	0.014	CbGeAlD
Tamoxifen—FMO1—lymph node—melanoma	0.000345	0.014	CbGeAlD
Tamoxifen—ESRRA—lymph node—melanoma	0.000339	0.0138	CbGeAlD
Tamoxifen—CES1—head—melanoma	0.000336	0.0137	CbGeAlD
Tamoxifen—CYP1B1—skin of body—melanoma	0.000328	0.0134	CbGeAlD
Tamoxifen—SIGMAR1—mammalian vulva—melanoma	0.000315	0.0128	CbGeAlD
Tamoxifen—FMO3—lymph node—melanoma	0.000298	0.0121	CbGeAlD
Tamoxifen—ESR2—head—melanoma	0.000291	0.0118	CbGeAlD
Tamoxifen—Dysphagia—Temozolomide—melanoma	0.00029	0.00224	CcSEcCtD
Tamoxifen—Pneumonia—Dactinomycin—melanoma	0.000287	0.00222	CcSEcCtD
Tamoxifen—Pancytopenia—Carmustine—melanoma	0.000285	0.0022	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000283	0.00219	CcSEcCtD
Tamoxifen—Neutropenia—Carmustine—melanoma	0.00028	0.00217	CcSEcCtD
Tamoxifen—Decreased appetite—Vemurafenib—melanoma	0.00028	0.00217	CcSEcCtD
Tamoxifen—Bronchitis—Temozolomide—melanoma	0.000279	0.00216	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Vemurafenib—melanoma	0.000278	0.00215	CcSEcCtD
Tamoxifen—Fatigue—Vemurafenib—melanoma	0.000278	0.00215	CcSEcCtD
Tamoxifen—Neoplasm—Docetaxel—melanoma	0.000278	0.00215	CcSEcCtD
Tamoxifen—Haemoglobin—Bleomycin—melanoma	0.000276	0.00214	CcSEcCtD
Tamoxifen—Constipation—Vemurafenib—melanoma	0.000276	0.00213	CcSEcCtD
Tamoxifen—Pancytopenia—Temozolomide—melanoma	0.000275	0.00213	CcSEcCtD
Tamoxifen—Haemorrhage—Bleomycin—melanoma	0.000275	0.00213	CcSEcCtD
Tamoxifen—Lightheadedness—Docetaxel—melanoma	0.000275	0.00213	CcSEcCtD
Tamoxifen—Hypoaesthesia—Bleomycin—melanoma	0.000274	0.00212	CcSEcCtD
Tamoxifen—Neutropenia—Temozolomide—melanoma	0.000271	0.0021	CcSEcCtD
Tamoxifen—Pneumonia—Carmustine—melanoma	0.000269	0.00208	CcSEcCtD
Tamoxifen—Erectile dysfunction—Temozolomide—melanoma	0.000267	0.00207	CcSEcCtD
Tamoxifen—Depression—Carmustine—melanoma	0.000267	0.00206	CcSEcCtD
Tamoxifen—Sepsis—Docetaxel—melanoma	0.000266	0.00206	CcSEcCtD
Tamoxifen—Weight increased—Temozolomide—melanoma	0.000264	0.00204	CcSEcCtD
Tamoxifen—Weight decreased—Temozolomide—melanoma	0.000262	0.00203	CcSEcCtD
Tamoxifen—ABCB1—blood vessel—melanoma	0.00026	0.0106	CbGeAlD
Tamoxifen—Urinary tract infection—Carmustine—melanoma	0.00026	0.00201	CcSEcCtD
Tamoxifen—Pneumonia—Temozolomide—melanoma	0.00026	0.00201	CcSEcCtD
Tamoxifen—Depression—Temozolomide—melanoma	0.000258	0.00199	CcSEcCtD
Tamoxifen—Hepatitis—Dactinomycin—melanoma	0.000256	0.00198	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000256	0.00198	CcSEcCtD
Tamoxifen—Flushing—Bleomycin—melanoma	0.000255	0.00198	CcSEcCtD
Tamoxifen—Pharyngitis—Dactinomycin—melanoma	0.000254	0.00197	CcSEcCtD
Tamoxifen—Swelling—Docetaxel—melanoma	0.000253	0.00196	CcSEcCtD
Tamoxifen—Urinary tract infection—Temozolomide—melanoma	0.000251	0.00194	CcSEcCtD
Tamoxifen—Hepatic failure—Docetaxel—melanoma	0.000248	0.00192	CcSEcCtD
Tamoxifen—Alopecia—Bleomycin—melanoma	0.000243	0.00188	CcSEcCtD
Tamoxifen—Erythema multiforme—Dactinomycin—melanoma	0.000242	0.00188	CcSEcCtD
Tamoxifen—Sinusitis—Temozolomide—melanoma	0.000242	0.00188	CcSEcCtD
Tamoxifen—Haemoglobin—Carmustine—melanoma	0.000241	0.00187	CcSEcCtD
Tamoxifen—Haemorrhage—Carmustine—melanoma	0.00024	0.00186	CcSEcCtD
Tamoxifen—Erythema—Bleomycin—melanoma	0.000239	0.00185	CcSEcCtD
Tamoxifen—Hypoaesthesia—Carmustine—melanoma	0.000239	0.00185	CcSEcCtD
Tamoxifen—Hot flush—Docetaxel—melanoma	0.000238	0.00184	CcSEcCtD
Tamoxifen—Flushing—Dactinomycin—melanoma	0.000238	0.00184	CcSEcCtD
Tamoxifen—Hypersensitivity—Vemurafenib—melanoma	0.000237	0.00184	CcSEcCtD
Tamoxifen—Oedema peripheral—Carmustine—melanoma	0.000236	0.00183	CcSEcCtD
Tamoxifen—Menopausal symptoms—Docetaxel—melanoma	0.000236	0.00183	CcSEcCtD
Tamoxifen—Visual disturbance—Docetaxel—melanoma	0.000235	0.00182	CcSEcCtD
Tamoxifen—CES1—lymph node—melanoma	0.000235	0.00957	CbGeAlD
Tamoxifen—Dermatitis bullous—Docetaxel—melanoma	0.000233	0.00181	CcSEcCtD
Tamoxifen—Haemoglobin—Temozolomide—melanoma	0.000233	0.0018	CcSEcCtD
Tamoxifen—CYP1A1—skin of body—melanoma	0.000232	0.00945	CbGeAlD
Tamoxifen—Haemorrhage—Temozolomide—melanoma	0.000232	0.0018	CcSEcCtD
Tamoxifen—Hepatitis—Temozolomide—melanoma	0.000232	0.0018	CcSEcCtD
Tamoxifen—Asthenia—Vemurafenib—melanoma	0.000231	0.00179	CcSEcCtD
Tamoxifen—Visual impairment—Carmustine—melanoma	0.000231	0.00179	CcSEcCtD
Tamoxifen—Hypoaesthesia—Temozolomide—melanoma	0.000231	0.00179	CcSEcCtD
Tamoxifen—Pharyngitis—Temozolomide—melanoma	0.00023	0.00178	CcSEcCtD
Tamoxifen—CYP19A1—head—melanoma	0.000229	0.00933	CbGeAlD
Tamoxifen—Oedema peripheral—Temozolomide—melanoma	0.000228	0.00177	CcSEcCtD
Tamoxifen—Pruritus—Vemurafenib—melanoma	0.000228	0.00177	CcSEcCtD
Tamoxifen—Alopecia—Dactinomycin—melanoma	0.000227	0.00175	CcSEcCtD
Tamoxifen—CYP2B6—skin of body—melanoma	0.000226	0.00918	CbGeAlD
Tamoxifen—Visual impairment—Temozolomide—melanoma	0.000223	0.00173	CcSEcCtD
Tamoxifen—Erythema—Dactinomycin—melanoma	0.000223	0.00173	CcSEcCtD
Tamoxifen—ABCG2—mammalian vulva—melanoma	0.000223	0.00908	CbGeAlD
Tamoxifen—Flushing—Carmustine—melanoma	0.000223	0.00172	CcSEcCtD
Tamoxifen—Anaemia—Bleomycin—melanoma	0.000221	0.00171	CcSEcCtD
Tamoxifen—Diarrhoea—Vemurafenib—melanoma	0.000221	0.00171	CcSEcCtD
Tamoxifen—Erythema multiforme—Temozolomide—melanoma	0.000219	0.0017	CcSEcCtD
Tamoxifen—Flushing—Temozolomide—melanoma	0.000215	0.00167	CcSEcCtD
Tamoxifen—Arrhythmia—Carmustine—melanoma	0.000214	0.00166	CcSEcCtD
Tamoxifen—CYP1B1—head—melanoma	0.000214	0.00872	CbGeAlD
Tamoxifen—Leukopenia—Bleomycin—melanoma	0.000214	0.00166	CcSEcCtD
Tamoxifen—Dizziness—Vemurafenib—melanoma	0.000213	0.00165	CcSEcCtD
Tamoxifen—Alopecia—Carmustine—melanoma	0.000212	0.00164	CcSEcCtD
Tamoxifen—CYP1A1—mammalian vulva—melanoma	0.000212	0.00862	CbGeAlD
Tamoxifen—Erythema—Carmustine—melanoma	0.000209	0.00162	CcSEcCtD
Tamoxifen—Cough—Bleomycin—melanoma	0.000209	0.00162	CcSEcCtD
Tamoxifen—Anaemia—Dactinomycin—melanoma	0.000206	0.0016	CcSEcCtD
Tamoxifen—Liver function test abnormal—Docetaxel—melanoma	0.000206	0.00159	CcSEcCtD
Tamoxifen—Vomiting—Vemurafenib—melanoma	0.000205	0.00159	CcSEcCtD
Tamoxifen—Alopecia—Temozolomide—melanoma	0.000205	0.00159	CcSEcCtD
Tamoxifen—Chest pain—Bleomycin—melanoma	0.000204	0.00158	CcSEcCtD
Tamoxifen—Myalgia—Bleomycin—melanoma	0.000204	0.00158	CcSEcCtD
Tamoxifen—ESR2—lymph node—melanoma	0.000204	0.00829	CbGeAlD
Tamoxifen—Rash—Vemurafenib—melanoma	0.000203	0.00157	CcSEcCtD
Tamoxifen—Dermatitis—Vemurafenib—melanoma	0.000203	0.00157	CcSEcCtD
Tamoxifen—Back pain—Carmustine—melanoma	0.000202	0.00156	CcSEcCtD
Tamoxifen—Headache—Vemurafenib—melanoma	0.000202	0.00156	CcSEcCtD
Tamoxifen—Erythema—Temozolomide—melanoma	0.000202	0.00156	CcSEcCtD
Tamoxifen—Discomfort—Bleomycin—melanoma	0.000201	0.00156	CcSEcCtD
Tamoxifen—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000201	0.00155	CcSEcCtD
Tamoxifen—Cramp muscle—Docetaxel—melanoma	0.000201	0.00155	CcSEcCtD
Tamoxifen—Leukopenia—Dactinomycin—melanoma	0.0002	0.00155	CcSEcCtD
Tamoxifen—ESR1—head—melanoma	0.000199	0.00811	CbGeAlD
Tamoxifen—Dysgeusia—Temozolomide—melanoma	0.000198	0.00153	CcSEcCtD
Tamoxifen—Alanine aminotransferase increased—Docetaxel—melanoma	0.000197	0.00152	CcSEcCtD
Tamoxifen—Oedema—Bleomycin—melanoma	0.000195	0.00151	CcSEcCtD
Tamoxifen—Back pain—Temozolomide—melanoma	0.000195	0.00151	CcSEcCtD
Tamoxifen—Infection—Bleomycin—melanoma	0.000194	0.0015	CcSEcCtD
Tamoxifen—Anaemia—Carmustine—melanoma	0.000193	0.00149	CcSEcCtD
Tamoxifen—Dysphagia—Docetaxel—melanoma	0.000193	0.00149	CcSEcCtD
Tamoxifen—Nausea—Vemurafenib—melanoma	0.000191	0.00148	CcSEcCtD
Tamoxifen—Thrombocytopenia—Bleomycin—melanoma	0.000191	0.00148	CcSEcCtD
Tamoxifen—Myalgia—Dactinomycin—melanoma	0.00019	0.00147	CcSEcCtD
Tamoxifen—Discomfort—Dactinomycin—melanoma	0.000188	0.00145	CcSEcCtD
Tamoxifen—Angina pectoris—Docetaxel—melanoma	0.000188	0.00145	CcSEcCtD
Tamoxifen—Leukopenia—Carmustine—melanoma	0.000187	0.00145	CcSEcCtD
Tamoxifen—Anaemia—Temozolomide—melanoma	0.000187	0.00144	CcSEcCtD
Tamoxifen—Anorexia—Bleomycin—melanoma	0.000186	0.00144	CcSEcCtD
Tamoxifen—Angioedema—Temozolomide—melanoma	0.000184	0.00143	CcSEcCtD
Tamoxifen—Pancytopenia—Docetaxel—melanoma	0.000183	0.00142	CcSEcCtD
Tamoxifen—Oedema—Dactinomycin—melanoma	0.000182	0.00141	CcSEcCtD
Tamoxifen—Infection—Dactinomycin—melanoma	0.000181	0.0014	CcSEcCtD
Tamoxifen—Leukopenia—Temozolomide—melanoma	0.000181	0.0014	CcSEcCtD
Tamoxifen—Hypertension—Carmustine—melanoma	0.00018	0.0014	CcSEcCtD
Tamoxifen—Neutropenia—Docetaxel—melanoma	0.00018	0.00139	CcSEcCtD
Tamoxifen—Thrombocytopenia—Dactinomycin—melanoma	0.000178	0.00138	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Bleomycin—melanoma	0.000178	0.00138	CcSEcCtD
Tamoxifen—Myalgia—Carmustine—melanoma	0.000178	0.00138	CcSEcCtD
Tamoxifen—Chest pain—Carmustine—melanoma	0.000178	0.00138	CcSEcCtD
Tamoxifen—Anxiety—Carmustine—melanoma	0.000177	0.00137	CcSEcCtD
Tamoxifen—Cough—Temozolomide—melanoma	0.000176	0.00136	CcSEcCtD
Tamoxifen—Paraesthesia—Bleomycin—melanoma	0.000175	0.00136	CcSEcCtD
Tamoxifen—Weight increased—Docetaxel—melanoma	0.000175	0.00136	CcSEcCtD
Tamoxifen—Weight decreased—Docetaxel—melanoma	0.000174	0.00135	CcSEcCtD
Tamoxifen—Hypertension—Temozolomide—melanoma	0.000174	0.00135	CcSEcCtD
Tamoxifen—Dyspnoea—Bleomycin—melanoma	0.000174	0.00135	CcSEcCtD
Tamoxifen—Anorexia—Dactinomycin—melanoma	0.000174	0.00134	CcSEcCtD
Tamoxifen—Pneumonia—Docetaxel—melanoma	0.000173	0.00134	CcSEcCtD
Tamoxifen—Arthralgia—Temozolomide—melanoma	0.000172	0.00133	CcSEcCtD
Tamoxifen—Myalgia—Temozolomide—melanoma	0.000172	0.00133	CcSEcCtD
Tamoxifen—Anxiety—Temozolomide—melanoma	0.000171	0.00133	CcSEcCtD
Tamoxifen—Oedema—Carmustine—melanoma	0.00017	0.00132	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Docetaxel—melanoma	0.00017	0.00132	CcSEcCtD
Tamoxifen—Discomfort—Temozolomide—melanoma	0.00017	0.00131	CcSEcCtD
Tamoxifen—Decreased appetite—Bleomycin—melanoma	0.00017	0.00131	CcSEcCtD
Tamoxifen—Infection—Carmustine—melanoma	0.000169	0.00131	CcSEcCtD
Tamoxifen—Acute coronary syndrome—Docetaxel—melanoma	0.000169	0.00131	CcSEcCtD
Tamoxifen—Myocardial infarction—Docetaxel—melanoma	0.000168	0.0013	CcSEcCtD
Tamoxifen—Dry mouth—Temozolomide—melanoma	0.000168	0.0013	CcSEcCtD
Tamoxifen—Pain—Bleomycin—melanoma	0.000167	0.00129	CcSEcCtD
Tamoxifen—Thrombocytopenia—Carmustine—melanoma	0.000167	0.00129	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000166	0.00128	CcSEcCtD
Tamoxifen—Oedema—Temozolomide—melanoma	0.000165	0.00128	CcSEcCtD
Tamoxifen—Infection—Temozolomide—melanoma	0.000164	0.00127	CcSEcCtD
Tamoxifen—Anorexia—Carmustine—melanoma	0.000162	0.00126	CcSEcCtD
Tamoxifen—Thrombocytopenia—Temozolomide—melanoma	0.000161	0.00125	CcSEcCtD
Tamoxifen—CYP19A1—lymph node—melanoma	0.00016	0.00653	CbGeAlD
Tamoxifen—Hyperhidrosis—Temozolomide—melanoma	0.000159	0.00123	CcSEcCtD
Tamoxifen—Decreased appetite—Dactinomycin—melanoma	0.000158	0.00123	CcSEcCtD
Tamoxifen—SIGMAR1—lymph node—melanoma	0.000158	0.00642	CbGeAlD
Tamoxifen—Fatigue—Dactinomycin—melanoma	0.000157	0.00122	CcSEcCtD
Tamoxifen—Anorexia—Temozolomide—melanoma	0.000157	0.00122	CcSEcCtD
Tamoxifen—Pain—Dactinomycin—melanoma	0.000156	0.00121	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Carmustine—melanoma	0.000155	0.0012	CcSEcCtD
Tamoxifen—Urticaria—Bleomycin—melanoma	0.000155	0.0012	CcSEcCtD
Tamoxifen—Haemoglobin—Docetaxel—melanoma	0.000155	0.0012	CcSEcCtD
Tamoxifen—Hepatitis—Docetaxel—melanoma	0.000154	0.00119	CcSEcCtD
Tamoxifen—Haemorrhage—Docetaxel—melanoma	0.000154	0.00119	CcSEcCtD
Tamoxifen—Insomnia—Carmustine—melanoma	0.000154	0.00119	CcSEcCtD
Tamoxifen—Hypoaesthesia—Docetaxel—melanoma	0.000153	0.00119	CcSEcCtD
Tamoxifen—ABCC2—lymph node—melanoma	0.000153	0.00623	CbGeAlD
Tamoxifen—Paraesthesia—Carmustine—melanoma	0.000153	0.00119	CcSEcCtD
Tamoxifen—Pharyngitis—Docetaxel—melanoma	0.000153	0.00118	CcSEcCtD
Tamoxifen—Dyspnoea—Carmustine—melanoma	0.000152	0.00118	CcSEcCtD
Tamoxifen—Oedema peripheral—Docetaxel—melanoma	0.000152	0.00118	CcSEcCtD
Tamoxifen—CYP1A1—head—melanoma	0.000151	0.00616	CbGeAlD
Tamoxifen—Musculoskeletal discomfort—Temozolomide—melanoma	0.00015	0.00116	CcSEcCtD
Tamoxifen—CYP1B1—lymph node—melanoma	0.00015	0.00611	CbGeAlD
Tamoxifen—Insomnia—Temozolomide—melanoma	0.000149	0.00115	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Dactinomycin—melanoma	0.000149	0.00115	CcSEcCtD
Tamoxifen—Visual impairment—Docetaxel—melanoma	0.000149	0.00115	CcSEcCtD
Tamoxifen—Decreased appetite—Carmustine—melanoma	0.000148	0.00115	CcSEcCtD
Tamoxifen—Paraesthesia—Temozolomide—melanoma	0.000148	0.00115	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Carmustine—melanoma	0.000147	0.00114	CcSEcCtD
Tamoxifen—CYP2B6—head—melanoma	0.000147	0.00599	CbGeAlD
Tamoxifen—Dyspnoea—Temozolomide—melanoma	0.000147	0.00114	CcSEcCtD
Tamoxifen—Erythema multiforme—Docetaxel—melanoma	0.000146	0.00113	CcSEcCtD
Tamoxifen—Constipation—Carmustine—melanoma	0.000146	0.00113	CcSEcCtD
Tamoxifen—Pain—Carmustine—melanoma	0.000146	0.00113	CcSEcCtD
Tamoxifen—Dyspepsia—Temozolomide—melanoma	0.000145	0.00112	CcSEcCtD
Tamoxifen—Abdominal pain—Dactinomycin—melanoma	0.000144	0.00111	CcSEcCtD
Tamoxifen—Hypersensitivity—Bleomycin—melanoma	0.000144	0.00111	CcSEcCtD
Tamoxifen—Decreased appetite—Temozolomide—melanoma	0.000143	0.00111	CcSEcCtD
Tamoxifen—Flushing—Docetaxel—melanoma	0.000143	0.00111	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Temozolomide—melanoma	0.000142	0.0011	CcSEcCtD
Tamoxifen—Fatigue—Temozolomide—melanoma	0.000142	0.0011	CcSEcCtD
Tamoxifen—Constipation—Temozolomide—melanoma	0.000141	0.00109	CcSEcCtD
Tamoxifen—Pain—Temozolomide—melanoma	0.000141	0.00109	CcSEcCtD
Tamoxifen—Asthenia—Bleomycin—melanoma	0.00014	0.00108	CcSEcCtD
Tamoxifen—ESR1—lymph node—melanoma	0.000139	0.00568	CbGeAlD
Tamoxifen—Gastrointestinal pain—Carmustine—melanoma	0.000139	0.00108	CcSEcCtD
Tamoxifen—Pruritus—Bleomycin—melanoma	0.000138	0.00107	CcSEcCtD
Tamoxifen—CYP2E1—head—melanoma	0.000138	0.00562	CbGeAlD
Tamoxifen—Arrhythmia—Docetaxel—melanoma	0.000138	0.00107	CcSEcCtD
Tamoxifen—ABCB1—retina—melanoma	0.000137	0.00559	CbGeAlD
Tamoxifen—Alopecia—Docetaxel—melanoma	0.000136	0.00105	CcSEcCtD
Tamoxifen—Abdominal pain—Carmustine—melanoma	0.000135	0.00104	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Temozolomide—melanoma	0.000135	0.00104	CcSEcCtD
Tamoxifen—Erythema—Docetaxel—melanoma	0.000134	0.00104	CcSEcCtD
Tamoxifen—Hypersensitivity—Dactinomycin—melanoma	0.000134	0.00104	CcSEcCtD
Tamoxifen—Dysgeusia—Docetaxel—melanoma	0.000131	0.00102	CcSEcCtD
Tamoxifen—Urticaria—Temozolomide—melanoma	0.000131	0.00101	CcSEcCtD
Tamoxifen—Asthenia—Dactinomycin—melanoma	0.000131	0.00101	CcSEcCtD
Tamoxifen—Abdominal pain—Temozolomide—melanoma	0.00013	0.00101	CcSEcCtD
Tamoxifen—Back pain—Docetaxel—melanoma	0.00013	0.00101	CcSEcCtD
Tamoxifen—Muscle spasms—Docetaxel—melanoma	0.000129	0.000999	CcSEcCtD
Tamoxifen—Hypersensitivity—Carmustine—melanoma	0.000126	0.000972	CcSEcCtD
Tamoxifen—Diarrhoea—Dactinomycin—melanoma	0.000125	0.000965	CcSEcCtD
Tamoxifen—Vomiting—Bleomycin—melanoma	0.000124	0.000961	CcSEcCtD
Tamoxifen—Anaemia—Docetaxel—melanoma	0.000124	0.00096	CcSEcCtD
Tamoxifen—Rash—Bleomycin—melanoma	0.000123	0.000953	CcSEcCtD
Tamoxifen—Dermatitis—Bleomycin—melanoma	0.000123	0.000952	CcSEcCtD
Tamoxifen—Asthenia—Carmustine—melanoma	0.000122	0.000947	CcSEcCtD
Tamoxifen—Hypersensitivity—Temozolomide—melanoma	0.000121	0.00094	CcSEcCtD
Tamoxifen—Leukopenia—Docetaxel—melanoma	0.00012	0.00093	CcSEcCtD
Tamoxifen—Asthenia—Temozolomide—melanoma	0.000118	0.000915	CcSEcCtD
Tamoxifen—Cough—Docetaxel—melanoma	0.000117	0.000907	CcSEcCtD
Tamoxifen—Diarrhoea—Carmustine—melanoma	0.000117	0.000903	CcSEcCtD
Tamoxifen—Pruritus—Temozolomide—melanoma	0.000117	0.000902	CcSEcCtD
Tamoxifen—Nausea—Bleomycin—melanoma	0.000116	0.000898	CcSEcCtD
Tamoxifen—Hypertension—Docetaxel—melanoma	0.000116	0.000897	CcSEcCtD
Tamoxifen—Vomiting—Dactinomycin—melanoma	0.000116	0.000897	CcSEcCtD
Tamoxifen—Rash—Dactinomycin—melanoma	0.000115	0.000889	CcSEcCtD
Tamoxifen—Chest pain—Docetaxel—melanoma	0.000114	0.000885	CcSEcCtD
Tamoxifen—Myalgia—Docetaxel—melanoma	0.000114	0.000885	CcSEcCtD
Tamoxifen—Arthralgia—Docetaxel—melanoma	0.000114	0.000885	CcSEcCtD
Tamoxifen—Dizziness—Carmustine—melanoma	0.000113	0.000873	CcSEcCtD
Tamoxifen—Diarrhoea—Temozolomide—melanoma	0.000113	0.000873	CcSEcCtD
Tamoxifen—Dry mouth—Docetaxel—melanoma	0.000112	0.000865	CcSEcCtD
Tamoxifen—ABCG2—lymph node—melanoma	0.000112	0.00455	CbGeAlD
Tamoxifen—ABCB1—mammalian vulva—melanoma	0.00011	0.00448	CbGeAlD
Tamoxifen—Oedema—Docetaxel—melanoma	0.00011	0.000848	CcSEcCtD
Tamoxifen—CYP2D6—head—melanoma	0.000109	0.00445	CbGeAlD
Tamoxifen—Dizziness—Temozolomide—melanoma	0.000109	0.000843	CcSEcCtD
Tamoxifen—Infection—Docetaxel—melanoma	0.000109	0.000843	CcSEcCtD
Tamoxifen—Vomiting—Carmustine—melanoma	0.000108	0.000839	CcSEcCtD
Tamoxifen—Nausea—Dactinomycin—melanoma	0.000108	0.000838	CcSEcCtD
Tamoxifen—Rash—Carmustine—melanoma	0.000107	0.000832	CcSEcCtD
Tamoxifen—Dermatitis—Carmustine—melanoma	0.000107	0.000831	CcSEcCtD
Tamoxifen—Thrombocytopenia—Docetaxel—melanoma	0.000107	0.00083	CcSEcCtD
Tamoxifen—Headache—Carmustine—melanoma	0.000107	0.000827	CcSEcCtD
Tamoxifen—CYP1A1—lymph node—melanoma	0.000106	0.00432	CbGeAlD
Tamoxifen—Vomiting—Temozolomide—melanoma	0.000105	0.000811	CcSEcCtD
Tamoxifen—Anorexia—Docetaxel—melanoma	0.000104	0.000808	CcSEcCtD
Tamoxifen—Rash—Temozolomide—melanoma	0.000104	0.000804	CcSEcCtD
Tamoxifen—Dermatitis—Temozolomide—melanoma	0.000104	0.000803	CcSEcCtD
Tamoxifen—Headache—Temozolomide—melanoma	0.000103	0.000799	CcSEcCtD
Tamoxifen—Nausea—Carmustine—melanoma	0.000101	0.000784	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Docetaxel—melanoma	9.98e-05	0.000773	CcSEcCtD
Tamoxifen—Insomnia—Docetaxel—melanoma	9.91e-05	0.000767	CcSEcCtD
Tamoxifen—Paraesthesia—Docetaxel—melanoma	9.84e-05	0.000762	CcSEcCtD
Tamoxifen—Nausea—Temozolomide—melanoma	9.79e-05	0.000758	CcSEcCtD
Tamoxifen—Dyspnoea—Docetaxel—melanoma	9.77e-05	0.000756	CcSEcCtD
Tamoxifen—Dyspepsia—Docetaxel—melanoma	9.64e-05	0.000747	CcSEcCtD
Tamoxifen—Decreased appetite—Docetaxel—melanoma	9.52e-05	0.000737	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Docetaxel—melanoma	9.46e-05	0.000732	CcSEcCtD
Tamoxifen—Fatigue—Docetaxel—melanoma	9.45e-05	0.000731	CcSEcCtD
Tamoxifen—Pain—Docetaxel—melanoma	9.37e-05	0.000725	CcSEcCtD
Tamoxifen—Constipation—Docetaxel—melanoma	9.37e-05	0.000725	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Docetaxel—melanoma	8.96e-05	0.000694	CcSEcCtD
Tamoxifen—Orphenadrine—SCN10A—melanoma	8.72e-05	0.302	CrCbGaD
Tamoxifen—Abdominal pain—Docetaxel—melanoma	8.66e-05	0.00067	CcSEcCtD
Tamoxifen—Hypersensitivity—Docetaxel—melanoma	8.07e-05	0.000625	CcSEcCtD
Tamoxifen—ABCB1—head—melanoma	7.87e-05	0.0032	CbGeAlD
Tamoxifen—Asthenia—Docetaxel—melanoma	7.86e-05	0.000609	CcSEcCtD
Tamoxifen—Pruritus—Docetaxel—melanoma	7.75e-05	0.0006	CcSEcCtD
Tamoxifen—Diarrhoea—Docetaxel—melanoma	7.5e-05	0.00058	CcSEcCtD
Tamoxifen—Dizziness—Docetaxel—melanoma	7.24e-05	0.000561	CcSEcCtD
Tamoxifen—Vomiting—Docetaxel—melanoma	6.97e-05	0.000539	CcSEcCtD
Tamoxifen—Rash—Docetaxel—melanoma	6.91e-05	0.000535	CcSEcCtD
Tamoxifen—Dermatitis—Docetaxel—melanoma	6.9e-05	0.000534	CcSEcCtD
Tamoxifen—Headache—Docetaxel—melanoma	6.86e-05	0.000531	CcSEcCtD
Tamoxifen—Nausea—Docetaxel—melanoma	6.51e-05	0.000504	CcSEcCtD
Tamoxifen—Diethylstilbestrol—ABCB1—melanoma	6.22e-05	0.216	CrCbGaD
Tamoxifen—ABCB1—lymph node—melanoma	5.51e-05	0.00224	CbGeAlD
Tamoxifen—Toremifene—ABCB1—melanoma	4.93e-05	0.171	CrCbGaD
Tamoxifen—Clomifene—ABCB1—melanoma	4.26e-05	0.148	CrCbGaD
Tamoxifen—Loperamide—ABCB1—melanoma	2.74e-05	0.0951	CrCbGaD
Tamoxifen—Methadone—ABCB1—melanoma	1.95e-05	0.0677	CrCbGaD
Tamoxifen—CYP1A1—Metabolism—ABCB1—melanoma	3.36e-06	3.29e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PRKCA—melanoma	3.35e-06	3.28e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	3.35e-06	3.28e-05	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—AKT1—melanoma	3.35e-06	3.28e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—FASN—melanoma	3.35e-06	3.28e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CYP1B1—melanoma	3.34e-06	3.27e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—ERCC2—melanoma	3.32e-06	3.25e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—KDR—melanoma	3.32e-06	3.25e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—SLC5A5—melanoma	3.32e-06	3.25e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.3e-06	3.23e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—SLC5A5—melanoma	3.29e-06	3.22e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PRKCA—melanoma	3.28e-06	3.21e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PRKCA—melanoma	3.28e-06	3.21e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CYP1B1—melanoma	3.26e-06	3.19e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—ERCC2—melanoma	3.26e-06	3.19e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PIK3CG—melanoma	3.25e-06	3.19e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—ERCC2—melanoma	3.25e-06	3.18e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GNAQ—melanoma	3.21e-06	3.14e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CD44—melanoma	3.21e-06	3.14e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—FN1—melanoma	3.2e-06	3.13e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GNAQ—melanoma	3.18e-06	3.11e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CD44—melanoma	3.18e-06	3.11e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PLA2G6—melanoma	3.15e-06	3.08e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PIK3CD—melanoma	3.15e-06	3.08e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PPARG—melanoma	3.14e-06	3.07e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PIK3CB—melanoma	3.13e-06	3.07e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—NOTCH1—melanoma	3.13e-06	3.06e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PIK3CD—melanoma	3.12e-06	3.05e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.11e-06	3.05e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—ALB—melanoma	3.11e-06	3.04e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PTGS2—melanoma	3.1e-06	3.04e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PRKCA—melanoma	3.1e-06	3.03e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CYP17A1—melanoma	3.09e-06	3.03e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.08e-06	3.02e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ABCB1—melanoma	3.08e-06	3.02e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—ALB—melanoma	3.08e-06	3.02e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CYP1B1—melanoma	3.07e-06	3.01e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—ERCC2—melanoma	3.07e-06	3e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CD80—melanoma	3.07e-06	3e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—KIT—melanoma	3.06e-06	3e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PIK3CG—melanoma	3.06e-06	3e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—APC—melanoma	3.06e-06	3e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	3.05e-06	2.99e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CYP1B1—melanoma	3.05e-06	2.98e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—EGF—melanoma	3.03e-06	2.96e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PIK3CB—melanoma	3.02e-06	2.95e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	3.01e-06	2.95e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PTGS2—melanoma	2.99e-06	2.93e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.95e-06	2.89e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GNA11—melanoma	2.92e-06	2.86e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—BRAF—melanoma	2.88e-06	2.82e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PIK3CD—melanoma	2.86e-06	2.8e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—FASN—melanoma	2.86e-06	2.8e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PRKCA—melanoma	2.84e-06	2.78e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—VCAN—melanoma	2.83e-06	2.77e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—ALB—melanoma	2.82e-06	2.76e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ERCC2—melanoma	2.81e-06	2.75e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—SLC5A5—melanoma	2.81e-06	2.75e-05	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—AKT1—melanoma	2.8e-06	2.75e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IGF1—melanoma	2.8e-06	2.74e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ABCB1—melanoma	2.75e-06	2.69e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PIK3CB—melanoma	2.74e-06	2.69e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PIK3CB—melanoma	2.72e-06	2.66e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PTGS2—melanoma	2.72e-06	2.66e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GNAQ—melanoma	2.72e-06	2.66e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CD44—melanoma	2.72e-06	2.66e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MAP2K1—melanoma	2.71e-06	2.65e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PTEN—melanoma	2.71e-06	2.65e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PTGS2—melanoma	2.7e-06	2.64e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PIK3CD—melanoma	2.69e-06	2.63e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.69e-06	2.63e-05	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—MAPK3—melanoma	2.66e-06	2.61e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.66e-06	2.6e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.64e-06	2.58e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CG—melanoma	2.63e-06	2.57e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PTEN—melanoma	2.61e-06	2.55e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CYP1B1—melanoma	2.6e-06	2.55e-05	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—MYC—melanoma	2.59e-06	2.54e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—FGF2—melanoma	2.58e-06	2.52e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CG—melanoma	2.57e-06	2.52e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CG—melanoma	2.57e-06	2.51e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.54e-06	2.49e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PPARG—melanoma	2.53e-06	2.48e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PRKCA—melanoma	2.53e-06	2.48e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ABCB1—melanoma	2.53e-06	2.48e-05	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—PIK3CA—melanoma	2.53e-06	2.48e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ERCC2—melanoma	2.51e-06	2.46e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ABCB1—melanoma	2.51e-06	2.46e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PIK3CB—melanoma	2.49e-06	2.44e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PPARG—melanoma	2.48e-06	2.43e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PPARG—melanoma	2.48e-06	2.42e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PRKCA—melanoma	2.47e-06	2.42e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PTGS2—melanoma	2.47e-06	2.42e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ERCC2—melanoma	2.45e-06	2.4e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CG—melanoma	2.42e-06	2.37e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MDM2—melanoma	2.41e-06	2.36e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP17A1—melanoma	2.39e-06	2.34e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—ERBB2—melanoma	2.38e-06	2.33e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PTEN—melanoma	2.37e-06	2.32e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PTEN—melanoma	2.35e-06	2.3e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PIK3CB—melanoma	2.35e-06	2.3e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PPARG—melanoma	2.34e-06	2.29e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.33e-06	2.28e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PRKCA—melanoma	2.33e-06	2.28e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ERCC2—melanoma	2.31e-06	2.26e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PRKCA—melanoma	2.31e-06	2.26e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CD—melanoma	2.31e-06	2.26e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.3e-06	2.25e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ERCC2—melanoma	2.29e-06	2.24e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—ALB—melanoma	2.28e-06	2.23e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CD—melanoma	2.26e-06	2.21e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CD—melanoma	2.26e-06	2.21e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GNA11—melanoma	2.26e-06	2.21e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CXCL8—melanoma	2.25e-06	2.21e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—ALB—melanoma	2.23e-06	2.18e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—ALB—melanoma	2.23e-06	2.18e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CG—melanoma	2.22e-06	2.18e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—FASN—melanoma	2.21e-06	2.16e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CDKN1B—melanoma	2.2e-06	2.15e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—SLC5A5—melanoma	2.17e-06	2.12e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CASP3—melanoma	2.16e-06	2.11e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PTEN—melanoma	2.15e-06	2.11e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL2—melanoma	2.15e-06	2.11e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PPARG—melanoma	2.15e-06	2.1e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ABCB1—melanoma	2.14e-06	2.1e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CD—melanoma	2.13e-06	2.09e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—ALB—melanoma	2.1e-06	2.06e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CCND1—melanoma	2.1e-06	2.05e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GNAQ—melanoma	2.1e-06	2.05e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CD44—melanoma	2.1e-06	2.05e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.08e-06	2.04e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CTNNB1—melanoma	2.08e-06	2.03e-05	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—AKT1—melanoma	2.07e-06	2.02e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MMP9—melanoma	2.04e-06	2e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CDKN1A—melanoma	2.03e-06	1.99e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PTEN—melanoma	2.03e-06	1.98e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—NFKB1—melanoma	2.02e-06	1.97e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CB—melanoma	2.01e-06	1.97e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP1B1—melanoma	2.01e-06	1.97e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PTGS2—melanoma	1.99e-06	1.95e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CG—melanoma	1.98e-06	1.94e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PRKCA—melanoma	1.97e-06	1.93e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CB—melanoma	1.97e-06	1.93e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CB—melanoma	1.97e-06	1.92e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ERCC2—melanoma	1.96e-06	1.92e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CD—melanoma	1.95e-06	1.91e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PTGS2—melanoma	1.95e-06	1.91e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PTGS2—melanoma	1.95e-06	1.91e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CG—melanoma	1.94e-06	1.9e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ALB—melanoma	1.93e-06	1.89e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PPARG—melanoma	1.91e-06	1.87e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PIK3CA—melanoma	1.91e-06	1.87e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.9e-06	1.86e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PPARG—melanoma	1.87e-06	1.83e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CB—melanoma	1.86e-06	1.82e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PTGS2—melanoma	1.84e-06	1.8e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PIK3CA—melanoma	1.84e-06	1.8e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—VEGFA—melanoma	1.83e-06	1.79e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CG—melanoma	1.82e-06	1.79e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—STAT3—melanoma	1.81e-06	1.77e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CG—melanoma	1.81e-06	1.77e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—NRAS—melanoma	1.81e-06	1.77e-05	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—AKT1—melanoma	1.8e-06	1.76e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PPARG—melanoma	1.76e-06	1.72e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PPARG—melanoma	1.75e-06	1.71e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CD—melanoma	1.74e-06	1.71e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PTEN—melanoma	1.74e-06	1.7e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MAPK3—melanoma	1.73e-06	1.69e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ALB—melanoma	1.72e-06	1.69e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CB—melanoma	1.7e-06	1.67e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PTEN—melanoma	1.7e-06	1.67e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CD—melanoma	1.7e-06	1.67e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PTEN—melanoma	1.7e-06	1.66e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PTGS2—melanoma	1.69e-06	1.65e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MYC—melanoma	1.68e-06	1.65e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ALB—melanoma	1.68e-06	1.64e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PIK3CA—melanoma	1.67e-06	1.64e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PIK3CA—melanoma	1.66e-06	1.62e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ABCB1—melanoma	1.66e-06	1.62e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MAPK1—melanoma	1.65e-06	1.61e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—EGFR—melanoma	1.65e-06	1.61e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.62e-06	1.59e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PTEN—melanoma	1.61e-06	1.57e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CD—melanoma	1.6e-06	1.57e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CD—melanoma	1.59e-06	1.56e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ALB—melanoma	1.58e-06	1.55e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ALB—melanoma	1.57e-06	1.54e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—AKT1—melanoma	1.56e-06	1.53e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—KRAS—melanoma	1.56e-06	1.52e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CG—melanoma	1.55e-06	1.51e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PRKCA—melanoma	1.52e-06	1.49e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CB—melanoma	1.52e-06	1.49e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PIK3CA—melanoma	1.52e-06	1.49e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ERCC2—melanoma	1.51e-06	1.48e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PTGS2—melanoma	1.51e-06	1.47e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—AKT1—melanoma	1.5e-06	1.47e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PPARG—melanoma	1.49e-06	1.46e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CB—melanoma	1.48e-06	1.45e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PTEN—melanoma	1.47e-06	1.44e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PTGS2—melanoma	1.47e-06	1.44e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PIK3CA—melanoma	1.43e-06	1.4e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CB—melanoma	1.4e-06	1.37e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CB—melanoma	1.39e-06	1.36e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PTGS2—melanoma	1.39e-06	1.36e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TP53—melanoma	1.38e-06	1.35e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PTGS2—melanoma	1.37e-06	1.34e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—AKT1—melanoma	1.37e-06	1.34e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CD—melanoma	1.36e-06	1.33e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—AKT1—melanoma	1.35e-06	1.33e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ALB—melanoma	1.34e-06	1.31e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—HRAS—melanoma	1.32e-06	1.29e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PTEN—melanoma	1.31e-06	1.29e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PTEN—melanoma	1.28e-06	1.25e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL6—melanoma	1.27e-06	1.24e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—AKT1—melanoma	1.24e-06	1.22e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CA—melanoma	1.23e-06	1.2e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PTEN—melanoma	1.21e-06	1.18e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CA—melanoma	1.2e-06	1.18e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CA—melanoma	1.2e-06	1.17e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PTEN—melanoma	1.2e-06	1.17e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CG—melanoma	1.19e-06	1.17e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CB—melanoma	1.18e-06	1.16e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PTGS2—melanoma	1.17e-06	1.15e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—AKT1—melanoma	1.17e-06	1.14e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PPARG—melanoma	1.15e-06	1.13e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CA—melanoma	1.13e-06	1.11e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CD—melanoma	1.05e-06	1.03e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CA—melanoma	1.04e-06	1.02e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ALB—melanoma	1.04e-06	1.01e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PTEN—melanoma	1.02e-06	1e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—AKT1—melanoma	1e-06	9.81e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—AKT1—melanoma	9.81e-07	9.6e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—AKT1—melanoma	9.79e-07	9.58e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CA—melanoma	9.27e-07	9.07e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—AKT1—melanoma	9.25e-07	9.06e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CB—melanoma	9.14e-07	8.95e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PTGS2—melanoma	9.06e-07	8.87e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CA—melanoma	9.05e-07	8.85e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CA—melanoma	8.52e-07	8.34e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—AKT1—melanoma	8.48e-07	8.3e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CA—melanoma	8.45e-07	8.27e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PTEN—melanoma	7.9e-07	7.73e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—AKT1—melanoma	7.57e-07	7.41e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—AKT1—melanoma	7.39e-07	7.23e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CA—melanoma	7.22e-07	7.07e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—AKT1—melanoma	6.96e-07	6.82e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—AKT1—melanoma	6.9e-07	6.76e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—AKT1—melanoma	5.9e-07	5.77e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CA—melanoma	5.57e-07	5.45e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—AKT1—melanoma	4.55e-07	4.46e-06	CbGpPWpGaD
